As reported in today's Olympia (Wash.) Olympian, the FDA's Pediatric Ethics subcommittee will meet on Sept. 10 to discuss whether "[i]t is ethical in the name of science to give a healthy child as young as 9 a controlled substance." The story continues:
The research, proposed by the National Institute of Mental Health, includes healthy children among 9- to 18-year-olds who would receive a single